{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:02:33Z","timestamp":1793714553741,"version":"4.6.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11566-2","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:00:27Z","timestamp":1759399227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning"],"prefix":"10.1186","volume":"25","author":[{"given":"En-Li","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"11566_CR1","unstructured":"World Health Organization. Global tuberculosis report. 2024. Available at: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/. Accessed 24 Jan 2025."},{"issue":"7","key":"11566_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S1473-3099(24)00007-0","volume":"24","author":"GBD 2021 Tuberculosis Collaborators","year":"2024","unstructured":"GBD 2021 Tuberculosis Collaborators. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO end TB strategy: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024;24(7):698\u2013725.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11566_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40249-025-01324-6","volume":"14","author":"MJ Saunders","year":"2025","unstructured":"Saunders MJ, Montoya R, Quevedo L, Ramos E, Datta S, Evans CA. The social determinants of tuberculosis: a case-control study characterising pathways to equitable intervention in Peru. Infect Dis Poverty. 2025;14(1):53.","journal-title":"Infect Dis Poverty"},{"key":"11566_CR4","doi-asserted-by":"publisher","first-page":"100072","DOI":"10.1016\/j.soh.2024.100072","volume":"3","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen W, Cheng Z, Chen Y, Li M, Ma L, et al. Global burden of HIV-negative multidrug- and extensively drug-resistant tuberculosis based on Global Burden of Disease Study 2021. Sci One Health. 2024;3:100072.","journal-title":"Sci One Health."},{"issue":"1","key":"11566_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40249-025-01299-4","volume":"14","author":"Y Wang","year":"2025","unstructured":"Wang Y, Liu X, Li Y, Liu M, Wang Y, Zhang H, et al. Association of urbanization-related factors with tuberculosis incidence among 1992 counties in China from 2005 to 2019: a nationwide observational study. Infect Dis Poverty. 2025;14(1):30.","journal-title":"Infect Dis Poverty"},{"issue":"Suppl 1","key":"11566_CR6","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ijid.2022.03.026","volume":"124","author":"S Tiberi","year":"2022","unstructured":"Tiberi S, Utjesanovic N, Galvin J, Centis R, D\u2019Ambrosio L, van den Boom M, et al. Drug resistant TB - latest developments in epidemiology, diagnostics and management. Int J Infect Dis. 2022;124(Suppl 1):S20-25.","journal-title":"Int J Infect Dis."},{"key":"11566_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijid.2023.04.392","volume":"132","author":"G Diriba","year":"2023","unstructured":"Diriba G, Alemu A, Yenew B, Tola HH, Gamtesa DF, Mollalign H, et al. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2023;132:50\u201363.","journal-title":"Int J Infect Dis"},{"issue":"10440","key":"11566_CR8","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10440","key":"11566_CR9","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2100\u201332.","journal-title":"Lancet"},{"key":"11566_CR10","doi-asserted-by":"publisher","first-page":"102873","DOI":"10.1016\/j.eclinm.2024.102873","volume":"77","author":"Z Bai","year":"2024","unstructured":"Bai Z, Han J, An J, Wang H, Du X, Yang Z, et al. The global, regional, and national patterns of change in the burden of congenital birth defects, 1990\u20132021: an analysis of the global burden of disease study 2021 and forecast to 2040. EClinicalMedicine. 2024;77:102873.","journal-title":"EClinicalMedicine."},{"issue":"1","key":"11566_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(24)00295-9","volume":"13","author":"GBD 2021 Pulmonary Arterial Hypertension Collaborators","year":"2025","unstructured":"GBD 2021 Pulmonary Arterial Hypertension Collaborators. Global, regional, and national burden of pulmonary arterial hypertension, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Respir Med. 2025;13(1):69\u201379.","journal-title":"Lancet Respir Med."},{"key":"11566_CR12","doi-asserted-by":"publisher","first-page":"100294","DOI":"10.1016\/j.lansea.2023.100294","volume":"22","author":"BW Lestari","year":"2023","unstructured":"Lestari BW, Nijman G, Larasmanah A, Soeroto AY, Santoso P, Alisjahbana B, et al. Management of drug-resistant tuberculosis in Indonesia: a four-year cascade of care analysis. Lancet Reg Health Southeast Asia. 2023;22:100294.","journal-title":"Lancet Reg Health Southeast Asia."},{"issue":"6","key":"11566_CR13","doi-asserted-by":"publisher","first-page":"101081","DOI":"10.1016\/j.lanmic.2025.101081","volume":"6","author":"L Barenghi","year":"2025","unstructured":"Barenghi L, Pellegrini M, Barenghi A. WHO global research priorities for antimicrobial resistance in human health. Lancet Microbe. 2025;6(6):101081.","journal-title":"Lancet Microbe"},{"issue":"1","key":"11566_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40249-024-01234-z","volume":"13","author":"XC Li","year":"2024","unstructured":"Li XC, Zhang YY, Zhang QY, Liu JS, Ran JJ, Han LF, et al. Global burden of viral infectious diseases of poverty based on Global Burden of Diseases Study 2021. Infect Dis Poverty. 2024;13(1):71.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"11566_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-024-01260-x","volume":"13","author":"YS Zhu","year":"2024","unstructured":"Zhu YS, Sun ZS, Zheng JX, Zhang SX, Yin JX, Zhao HQ, et al. Prevalence and attributable health burdens of vector-borne parasitic infectious diseases of poverty, 1990\u20132021: findings from the global burden of disease study 2021. Infect Dis Poverty. 2024;13(1):96.","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"11566_CR16","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.soh.2024.100086","volume":"1","author":"C Chu","year":"2024","unstructured":"Chu C, Yang G, Yang J, Liang D, Liu R, Chen G, et al. Trends in epidemiological characteristics and etiologies of diarrheal disease in children under five: an ecological study based on Global Burden of Disease study 2021. Sci One Health. 2024;1(3):100086.","journal-title":"Sci One Health."},{"key":"11566_CR17","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.soh.2024.100084","volume":"3","author":"SX Zhang","year":"2024","unstructured":"Zhang SX, Liu YJ, Tan EL, Yang GB, Wang Y, Hu XJ, et al. Global, regional, and national burden of upper respiratory infections, 1990\u20132021: Findings from the Global Burden of Disease study 2021. Sci One Health. 2024;3:100084.","journal-title":"Sci One Health."},{"issue":"1","key":"11566_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40249-022-01009-4","volume":"11","author":"Z Dong","year":"2022","unstructured":"Dong Z, Wang QQ, Yu SC, Huang F, Liu JJ, Yao HY, et al. Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China, 2006\u20132020. Infect Dis Poverty. 2022;11(1):85.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"11566_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40249-025-01345-1","volume":"14","author":"YR Xiao","year":"2025","unstructured":"Xiao YR, Ren X, Zhang MD, Zhu H, Wang X, Sun WS, et al. Analysis of regional characteristics in mortality trends of three chronic infectious diseases among the elderly in China, 2004\u20132021. Infect Dis Poverty. 2025;14(1):70.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"11566_CR20","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1186\/s12889-024-20624-4","volume":"24","author":"J Zhang","year":"2024","unstructured":"Zhang J, Ou D, Xie A, Chen D, Li X. Global burden and cross-country health inequalities of early-onset colorectal cancer and its risk factors from 1990 to 2021 and its projection until 2036. BMC Public Health. 2024;24(1):3124.","journal-title":"BMC Public Health"},{"issue":"1","key":"11566_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"GBD 2015 Obesity Collaborators","year":"2017","unstructured":"GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13\u201327.","journal-title":"N Engl J Med."},{"issue":"11","key":"11566_CR22","doi-asserted-by":"publisher","first-page":"e039935","DOI":"10.1136\/bmjopen-2020-039935","volume":"10","author":"N Mistry","year":"2020","unstructured":"Mistry N, Hemler EC, Dholakia Y, Bromage S, Shukla A, Dev P, et al. Protocol for a case-control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India. BMJ Open. 2020;10(11):e039935.","journal-title":"BMJ Open."},{"key":"11566_CR23","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.2147\/IDR.S412951","volume":"16","author":"A Seid","year":"2023","unstructured":"Seid A, Girma Y, Abebe A, Dereb E, Kassa M, Berhane N. Characteristics of TB\/HIV co-infection and patterns of multidrug-resistance tuberculosis in the Northwest Amhara, Ethiopia. Infect Drug Resist. 2023;16:3829\u201345.","journal-title":"Infect Drug Resist"},{"key":"11566_CR24","doi-asserted-by":"publisher","first-page":"1047659","DOI":"10.3389\/fpubh.2022.1047659","volume":"10","author":"L Zhou","year":"2022","unstructured":"Zhou L, Wu B, Huang F, Liu Z, Wang F, Zhang M, et al. Drug resistance patterns and dynamics of tuberculosis in Zhejiang Province, China: Results from five periodic longitudinal surveys. Front Public Health. 2022;10:1047659.","journal-title":"Front Public Health."},{"issue":"1","key":"11566_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1186\/s12879-024-09562-z","volume":"24","author":"T Maya","year":"2024","unstructured":"Maya T, Wilfred A, Lubinza C, Mfaume S, Mafie M, Mtunga D, et al. Diagnostic accuracy of the Xpert\u00ae MTB\/XDR assay for detection of Isoniazid and second-line antituberculosis drugs resistance at central TB reference laboratory in Tanzania. BMC Infect Dis. 2024;24(1):672.","journal-title":"BMC Infect Dis."},{"issue":"11","key":"11566_CR26","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1039\/D2MD00155A","volume":"13","author":"LA Alshabani","year":"2022","unstructured":"Alshabani LA, Kumar A, Willcocks SJ, Srithiran G, Bhakta S, Estrada DF, et al. Synthesis, biological evaluation and computational studies of pyrazole derivatives as Mycobacterium tuberculosis CYP121A1 inhibitors. RSC Med Chem. 2022;13(11):1350\u201360.","journal-title":"RSC Med Chem."},{"issue":"14","key":"11566_CR27","doi-asserted-by":"publisher","first-page":"8706","DOI":"10.3390\/ijerph19148706","volume":"19","author":"V Smelov","year":"2022","unstructured":"Smelov V, Trusova O, Barbier S, Muwonge R, Grankov V, Rusovich V, et al. Rationale and purpose: The FLUTE study to evaluate fluorography mass screening for tuberculosis and other diseases, as conducted in Eastern Europe and Central Asia Countries. Int J Environ Res Public Health. 2022;19(14):8706.","journal-title":"Int J Environ Res Public Health."},{"issue":"1","key":"11566_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12889-024-17713-9","volume":"24","author":"DG Assefa","year":"2024","unstructured":"Assefa DG, Dememew ZG, Zeleke ED, Manyazewal T, Bedru A. Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):260.","journal-title":"BMC Public Health"},{"issue":"1","key":"11566_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40249-025-01338-0","volume":"14","author":"C Visek","year":"2025","unstructured":"Visek C, Mukiibi J, Nantale M, Nalutaaya A, Bich\u00e9 P, Sung J, et al. Patient experiences of tuberculosis treatment deferral after a trace Xpert Ultra result: a prospective cohort study. Infect Dis Poverty. 2025;14(1):68.","journal-title":"Infect Dis Poverty."},{"key":"11566_CR30","doi-asserted-by":"publisher","first-page":"1550199","DOI":"10.3389\/fpubh.2025.1550199","volume":"13","author":"Y Guo","year":"2025","unstructured":"Guo Y, Li J, Lin L. Trends and forecast of drug-resistant tuberculosis: a global perspective from the GBD study 2021. Front Public Health. 2025;13:1550199.","journal-title":"Front Public Health"},{"key":"11566_CR31","doi-asserted-by":"publisher","first-page":"1040176","DOI":"10.3389\/fpubh.2022.1040176","volume":"10","author":"MQ Zheng","year":"2022","unstructured":"Zheng MQ, Li XX, Xu R, Liu S, Rui ZY, Guo ZY, et al. Bibliometric analysis of tuberculosis molecular epidemiology based on CiteSpace. Front Public Health. 2022;10:1040176.","journal-title":"Front Public Health."},{"key":"11566_CR32","doi-asserted-by":"publisher","first-page":"789725","DOI":"10.3389\/fmicb.2022.789725","volume":"13","author":"MA Mohammed Adam","year":"2022","unstructured":"Mohammed Adam MA, Ebraheem RSM, Bedri SA. Statistical investigation of high culture contamination rates in mycobacteriology laboratory. Front Microbiol. 2022;13:789725.","journal-title":"Front Microbiol"},{"issue":"1","key":"11566_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4269\/ajtmh.23-0504","volume":"111","author":"C Wippel","year":"2024","unstructured":"Wippel C, Farro\u00f1ay S, Gilbert HN, Millones AK, Acosta D, Torres I, et al. Exploring the role of the private sector in tuberculosis detection and management in Lima, Peru: a mixed-methods patient pathway analysis. Am J Trop Med Hyg. 2024;111(1):168\u201375.","journal-title":"Am J Trop Med Hyg."},{"issue":"20","key":"11566_CR34","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1039\/D4LC00340C","volume":"24","author":"X Qian","year":"2024","unstructured":"Qian X, Xu Q, Lyon CJ, Hu TY. CRISPR for companion diagnostics in low-resource settings. Lab Chip. 2024;24(20):4717\u201340.","journal-title":"Lab Chip"},{"issue":"1","key":"11566_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40249-019-0602-0","volume":"8","author":"JO Chen","year":"2019","unstructured":"Chen JO, Qiu YB, Rueda ZV, Hou JL, Lu KY, Chen LP, et al. Role of community-based active case finding in screening tuberculosis in Yunnan province of China. Infect Dis Poverty. 2019;8(1):92.","journal-title":"Infect Dis Poverty."},{"issue":"2","key":"11566_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40471-021-00269-2","volume":"8","author":"JI Garc\u00eda","year":"2021","unstructured":"Garc\u00eda JI, Allu\u00e9-Guardia A, Tampi RP, Restrepo BI, Torrelles JB. New developments and insights in the improvement of Mycobacterium tuberculosis vaccines and diagnostics within the End TB strategy. Curr Epidemiol Rep. 2021;8(2):33\u201345.","journal-title":"Curr Epidemiol Rep"},{"issue":"15","key":"11566_CR37","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.2147\/RMHP.S386012","volume":"12","author":"A Abebe","year":"2022","unstructured":"Abebe A, Nuriye S, Baza D, Markos M, Woldeyohanes S, Gelgelu TB. Experience and perception of healthcare workers on the challenges of follow-up and treatment of tuberculosis patients in Southern Ethiopia: an exploratory-descriptive qualitative study. Risk Manag Healthc Policy. 2022;12(15):1931\u201345.","journal-title":"Risk Manag Healthc Policy"},{"key":"11566_CR38","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.2147\/IDR.S467971","volume":"17","author":"L Zou","year":"2024","unstructured":"Zou L, Kang W, Guo C, Du J, Chen Q, Shi Z, et al. Treatment outcomes and associated influencing factors among patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China. Infect Drug Resist. 2024;17:3737\u201349.","journal-title":"Infect Drug Resist."},{"issue":"1","key":"11566_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12941-024-00737-9","volume":"23","author":"BZ Katale","year":"2024","unstructured":"Katale BZ, Rofael S, Elton L, Mbugi EV, Mpagama SG, Mtunga D, et al. Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report. Ann Clin Microbiol Antimicrob. 2024;23(1):76.","journal-title":"Ann Clin Microbiol Antimicrob."},{"issue":"3","key":"11566_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jped.2025.01.008","volume":"101","author":"EF Rubin","year":"2025","unstructured":"Rubin EF, Lucena SC, Bhering M, Gon\u00e7alves L, Falc\u00e3o F, Dalcolmo M, et al. Tuberculosis among young contacts of patients with multidrug-resistant pulmonary tuberculosis in a reference hospital. J Pediatr (Rio J). 2025;101(3):458\u201365.","journal-title":"J Pediatr (Rio J)."},{"issue":"1","key":"11566_CR41","doi-asserted-by":"publisher","first-page":"e061836","DOI":"10.1136\/bmjopen-2022-061836","volume":"13","author":"F Admassu","year":"2023","unstructured":"Admassu F, Abera E, Gizachew A, Sedoro T, Gari T. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study. BMJ Open. 2023;13(1):e061836.","journal-title":"BMJ Open"},{"issue":"1","key":"11566_CR42","first-page":"e000325","volume":"6","author":"MG L\u00f3pez","year":"2020","unstructured":"L\u00f3pez MG, Dogba JB, Torres-Puente M, Goig GA, Moreno-Molina M, Villamayor LM, et al. Tuberculosis in Liberia: high multidrug-resistance burden, transmission and diversity modelled by multiple importation events. Microb Genom. 2020;6(1):e000325.","journal-title":"Microb Genom"},{"key":"11566_CR43","first-page":"101262","volume":"54","author":"L Oldfield","year":"2024","unstructured":"Oldfield L, Penm J, Moles R. Exploring access to essential medicines in the South Pacific: insights from a multi-country cross-sectional study. Lancet Reg Health West Pac. 2024;54:101262.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"11566_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5365\/wpsar.2024.15.1.1056","volume":"15","author":"M Yanagawa","year":"2024","unstructured":"Yanagawa M, Gwali B, Kako H, Itogo N, Tanabose L, Morishita F. Epidemiology of and programmatic response to tuberculosis in Solomon Islands: analysis of surveillance data, 2016\u20132022. Western Pac Surveill Response J. 2024;15(1):1\u201310.","journal-title":"Western Pac Surveill Response J"},{"key":"11566_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijid.2015.01.001","volume":"32","author":"T Islam","year":"2015","unstructured":"Islam T, Marais BJ, Nhung NV, Chiang CY, Yew WW, Yoshiyama T, et al. Western Pacific Regional Green light committee: progress and way forward. Int J Infect Dis. 2015;32:161\u20135.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"11566_CR46","doi-asserted-by":"publisher","first-page":"e013280","DOI":"10.1136\/bmjgh-2023-013280","volume":"9","author":"AS Ferdinand","year":"2024","unstructured":"Ferdinand AS, McEwan C, Lin C, Betham K, Kandan K, Tamolsaian G, et al. Development of a cross-sectoral antimicrobial resistance capability assessment framework. BMJ Glob Health. 2024;9(1):e013280.","journal-title":"BMJ Glob Health"},{"issue":"1","key":"11566_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5365\/wpsar.2023.14.1.984","volume":"14","author":"M Yanagawa","year":"2023","unstructured":"Yanagawa M, Morishita F, Oh KH, Rahevar K, Islam TA, Yadav S. Epidemiology of tuberculosis in the Pacific island countries and areas, 2000\u20132020. Western Pac Surveill Response J. 2023;14(1):1\u201312.","journal-title":"Western Pac Surveill Response J"},{"key":"11566_CR48","doi-asserted-by":"publisher","first-page":"1374703","DOI":"10.3389\/fpubh.2024.1374703","volume":"12","author":"ID Otchere","year":"2024","unstructured":"Otchere ID, Asante-Poku A, Akpadja KF, Diallo AB, Sanou A, Asare P, et al. Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control. Front Public Health. 2024;12:1374703.","journal-title":"Front Public Health"},{"issue":"1","key":"11566_CR49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12889-024-18285-4","volume":"24","author":"R Hambwalula","year":"2024","unstructured":"Hambwalula R, Kagujje M, Mwaba I, Musonda D, Singini D, Mutti L, et al. Engagement of private health care facilities in TB management in Lusaka district of Zambia: lessons learned and achievements. BMC Public Health. 2024;24(1):811.","journal-title":"BMC Public Health."},{"key":"11566_CR50","doi-asserted-by":"publisher","first-page":"04012","DOI":"10.7189\/jogh.15.04012","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Xi Y, Li Y, Zhou P, Xu C. Long-term impact of COVID-19-related nonpharmaceutical interventions on tuberculosis: an interrupted time series analysis using Bayesian method. J Glob Health. 2025;15:04012.","journal-title":"J Glob Health"},{"issue":"41","key":"11566_CR51","first-page":"907","volume":"4","author":"S Zhang","year":"2022","unstructured":"Zhang S, Qiu L, Wu D, Zhang S, Pan C, Li C, et al. Predictors for treatment outcomes in patients with multi-drug resistant tuberculosis - China, 2018\u20132020. China CDC Wkly. 2022;4(41):907\u201311.","journal-title":"China CDC Wkly."},{"issue":"25","key":"11566_CR52","first-page":"00223","volume":"S2090\u20131232","author":"JX Zheng","year":"2025","unstructured":"Zheng JX, Liu Y, Guan SY, Guo ZY, Duan L, Lv S, et al. Global, regional, and national burden of neglected tropical diseases and malaria in the general population, 1990\u20132021: Systematic analysis of the global burden of disease study 2021. J Adv Res. 2025;S2090\u20131232(25):00223\u201331.","journal-title":"J Adv Res"},{"issue":"10440","key":"11566_CR53","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"10459","key":"11566_CR54","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet."},{"key":"11566_CR55","doi-asserted-by":"publisher","first-page":"e080969","DOI":"10.1136\/bmj-2024-080969","volume":"388","author":"GJ Yang","year":"2025","unstructured":"Yang GJ, Ouyang HQ, Zhao ZY, Li WH, Fall IS, Djirmay AG, et al. Discrepancies in neglected tropical diseases burden estimates in China: comparative study of real-world data and Global Burden of Disease 2021 data (2004\u20132020). BMJ. 2025;388:e080969.","journal-title":"BMJ."},{"issue":"1","key":"11566_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40249-025-01335-3","volume":"14","author":"YF Zhang","year":"2025","unstructured":"Zhang YF, Li SZ, Wang SW, Mu D, Chen X, Zhou S, et al. Zoonotic diseases in China: epidemiological trends, incidence forecasting, and comparative analysis between real-world surveillance data and Global Burden of Disease 2021 estimates. Infect Dis Poverty. 2025;14(1):60.","journal-title":"Infect Dis Poverty."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11566-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11566-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11566-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:04:34Z","timestamp":1759403074000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11566-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11566"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11566-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For Global Burden of Disease 2021 Study, a waiver of informed consent was reviewed and approved by the Institutional Review Board of the University of Washington (No. STUDY00009060). All the information about ethical standards is available through the official website ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1225"}}